Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Feb;44(2):250–261.

Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism

W D M Paton, R G Pertwee
PMCID: PMC1666020  PMID: 4668592

Abstract

1. Cannabis extract prolonged sleeping time in mice in a thermally neutral environment (30-32° C) in which hypothermia does not occur. The prolongation was dose related, just detectable at 50 mg/kg, and 4-fold at 500 mg/kg.

2. Under these conditions, ether sleeping time was not prolonged.

3. Cannabis extract inhibited the aerobic metabolism of phenazone by a microsome-rich 9,000 g supernatant of mouse liver homogenate capable of nicotinamide adenine dinucleotide phosphate (NADPH) generation.

4. Δ1-Tetrahydrocannabinol (Δ1-THC) prolonged pentobarbitone sleep and inhibited phenazone metabolism, but its action was limited, and could not account for the effect of the extract. The carotenes and water-soluble fractions of the extract were inactive on pentobarbitone sleep.

5. Cannabidiol was strongly active by both tests; in vivo 39·8 μM/kg (12·5 mg/kg) prolonged sleep by 190%, and in vitro 12·7 μM inhibited phenazone metabolism 20%. These actions were dose related, and could account for the effect of the extract.

6. The prolongation of pentobarbitone sleep by cannabis extract in a dose of 200 mg/kg, intraperitoneally, was maximal when given 30 min before the pentobarbitone, still present at 3 h, but undetectable at 24 hours. No phase of enhanced metabolism at 24 or 48 h after single cannabis injection was detected.

7. It is concluded that cannabis extract inhibits microsomal activity of mouse liver, chiefly by virtue of its cannabidiol content. It is probable that cannabis consumption by man could lead to altered disposal of many other drugs, used in medicine or otherwise.

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOSE B. C., SAIFI A. Q., BHAGWAT A. W. Effect of cannabis indica on hexobarbital sleeping time and tissue respiration of rat brain. Arch Int Pharmacodyn Ther. 1963 Feb 1;141:520–524. [PubMed] [Google Scholar]
  2. DAGIRMANJIAN R., BOYD E. S. Some pharmacological effects of two tetrahydrocannabinols. J Pharmacol Exp Ther. 1962 Jan;135:25–33. [PubMed] [Google Scholar]
  3. Foltz R. L., Fentiman A. F., Jr, Leighty F. G., Walter J. L., Drewes H. R., Schwartz W. E., Page T. F., Jr, Truitt E. B., Jr Metabolite of (-)-trans-delta 8-tetrahydrocannabinol: identification and synthesis. Science. 1970 May 15;168(3933):844–845. doi: 10.1126/science.168.3933.844. [DOI] [PubMed] [Google Scholar]
  4. Garriott J. C., Forney R. B., Hughes F. W., Richards A. B. Pharmacologic properties of some cannabis related compounds. Arch Int Pharmacodyn Ther. 1968 Feb;171(2):425–434. [PubMed] [Google Scholar]
  5. Garriott J. C., King L. J., Forney R. B., Hughes F. W. Effects of some tetrahydrocannabinols on hexobarbital sleeping time and amphetamine induced hyperactivity in mice. Life Sci. 1967 Oct 1;6(19):2119–2128. doi: 10.1016/0024-3205(67)90232-9. [DOI] [PubMed] [Google Scholar]
  6. Gill E. W., Paton W. D., Pertwee R. G. Preliminary experiments on the chemistry and pharmacology of cannabis. Nature. 1970 Oct 10;228(5267):134–136. doi: 10.1038/228134a0. [DOI] [PubMed] [Google Scholar]
  7. JOHANNESSON T., ROGERS L. A., FOUTS J. R., WOODS L. A. THE EFFECT OF CODEINE TOLERANCE ON HEPATIC MICROSOMAL DRUG METABOLISM IN THE RAT. Acta Pharmacol Toxicol (Copenh) 1965;22:107–111. doi: 10.1111/j.1600-0773.1965.tb03501.x. [DOI] [PubMed] [Google Scholar]
  8. KATO R., CHIESARA E., VASSANELLI P. FURTHER STUDIES ON THE INHIBITION AND STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYMES OF RAT LIVER BY VARIOUS COMPOUNDS. Biochem Pharmacol. 1964 Jan;13:69–83. doi: 10.1016/0006-2952(64)90080-2. [DOI] [PubMed] [Google Scholar]
  9. Kubena R. K., Barry H., 3rd Interactions of delta-tetrahydrocannabinol with barbiturates and methamphetamine. J Pharmacol Exp Ther. 1970 May;173(1):94–100. [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Maître L., Staehelin M., Bein H. J. Effect of an extract of cannabis and of some cannabinols on catecholamine metabolism in rat brain and heart. Agents Actions. 1970 Mar;1(3):136–143. doi: 10.1007/BF01982400. [DOI] [PubMed] [Google Scholar]
  12. Neugebauer A., Splinter F. K., Häfke D., Kober R., Schirlitz H., Klinger W. Kinetische Untersuchungen über die enzymatische Hydroxylierung von Phenazon, oxydative O-Demethylierung von Kodein und N-Demethylierung von Aminophenazon durch Rattenlebermikrosomen. Biochem Pharmacol. 1969 Jul;18(7):1559–1576. doi: 10.1016/0006-2952(69)90143-9. [DOI] [PubMed] [Google Scholar]
  13. Schildkraut J. J., Efron D. H. The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Psychopharmacologia. 1971;20(2):191–196. doi: 10.1007/BF00404373. [DOI] [PubMed] [Google Scholar]
  14. Sofia R. D., Barry H., 3rd Depressant effect of delta-1-tetrahydrocannabinol enhanced by inhibition of its metabolism. Eur J Pharmacol. 1970;13(1):134–137. doi: 10.1016/0014-2999(70)90195-0. [DOI] [PubMed] [Google Scholar]
  15. WEBSTER S. H., LILJEGREN E. J. Organ: body-weight ratios for certain organs of laboratory animals. III. White swiss mouse. Am J Anat. 1955 Jul;97(1):129–153. doi: 10.1002/aja.1000970105. [DOI] [PubMed] [Google Scholar]
  16. Yoshimura H., Shimeno H., Tsukamoto H. Metabolism of drugs. LIX. A new metabolite of antipyrine. Biochem Pharmacol. 1968 Aug;17(8):1511–1516. doi: 10.1016/0006-2952(68)90210-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES